Welcome to our dedicated page for Blue Water Acqsn news (Ticker: BLUWU), a resource for investors and traders seeking the latest updates and insights on Blue Water Acqsn stock.
Blue Water Acquisition Corp. III reports developments as a Nasdaq-listed SPAC whose BLUWU units represent Class A ordinary shares and redeemable warrants. The company was formed as a Cayman Islands exempted blank-check company to pursue a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
Recurring news for Blue Water Acquisition Corp. III centers on IPO and trading mechanics, unit separation, warrant terms, capital-structure updates, shareholder-vote matters and governance. Company announcements also frame its stated search focus across artificial intelligence, biotechnology, healthcare and technology sectors without identifying a completed operating business.
Blue Water Acquisition Corp. (Nasdaq: BLUW) announced that its stockholders approved the Business Combination with Clarus Therapeutics, Inc. on August 27, 2021. Approximately 73.95% of shares were voted, with 69.57% in favor of the merger. Following the transaction, Blue Water will rebrand as Clarus Therapeutics Holdings, Inc., with new ticker symbols CRXT and CRXTW. Approximately $25.29 million will remain in the trust account post-redemptions. A detailed voting report will be filed with the SEC.
Blue Water Acquisition Corp. (BLUW) announced the postponement of its Special Meeting of Stockholders from August 12 to August 27, 2021. The meeting will take place at 10:00 a.m. ET via a live audio webcast. The deadline for stockholders to exercise redemption rights has been extended to August 25, 2021, at 5:00 p.m. ET. This meeting is related to the proposed business combination with Clarus Therapeutics, as outlined in the merger agreement dated April 27, 2021. Stockholders are urged to review the definitive proxy statement and other relevant documents available through the SEC.
Blue Water Acquisition Corp. (NASDAQ: BLUWU) announced a compliance issue with Nasdaq, receiving a notice for failing to timely file its Annual Report on Form 10-K for the year ending December 31, 2020. The notice has no immediate impact on trading. The company is reviewing its financial statements due to recent SEC guidance on SPAC warrant accounting. Blue Water has 60 days to submit a compliance plan, potentially extending the deadline for filing the Form 10-K to October 12, 2021.
Blue Water Acquisition Corp. announced that starting February 9, 2021, holders of the units from its initial public offering can separately trade shares of its Class A common stock and warrants. Shares will trade under the symbols BLUW and BLUWW on the Nasdaq, while unseparated units will continue under BLUWU. The offering was underwritten by Maxim Group LLC, and the public offering was made through a prospectus. Blue Water Acquisition Corp. aims to pursue business combinations, particularly in the healthcare sector.